UPDATE 1-NORDIC STOCKS - Factors to watch on July 4

Thu Jul 4, 2013 2:16am EDT

Related News

HELSINKI, July 4 (Reuters) - The following stocks may be affected by newspaper reports and other factors on Thursday:


The Danish biotech firm said its collaborator, drug giant GlaxoSmithKline Plc's, would start a new phase 3 study of ofatumumab to treat pemphigus vulgaris, a rare autoimmune disorder of the skin. Ofatumumab, Genmab's only drug, is sold under the name Arzerra for the treatment of blood cancer.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.